Shingles can strike decades after childhood chickenpox fades

A band of painful blisters that wraps around one side of the torso, often showing up in someone who has not thought about chickenpox since childhood, is usually the first sign that shingles has arrived. The condition traces back to the exact same virus responsible for that long-forgotten itchy rash, and the connection is not a coincidence or a separate infection picked up later in life. It is the identical virus, reactivating after spending decades doing nothing at all. Working out why a dormant virus wakes up, what it does once it does, and who ends up facing it explains why shingles remains a routine diagnosis among older adults even in places where chickenpox itself has become rare in children.

How the Chickenpox Virus Goes Into Hiding

The culprit behind both diseases is varicella-zoster virus, a member of the herpesvirus family that causes chickenpox on first exposure, usually in childhood. Once that initial infection clears and the visible rash fades, the virus does not leave the body the way a cold virus eventually does. It travels along nerve fibers and settles into clusters of nerve cell bodies near the spinal cord and brainstem, called sensory ganglia, where it goes dormant. In that latent state, the virus produces none of the symptoms associated with active infection and causes no detectable illness, sometimes for the rest of a person’s life. The immune system keeps it suppressed there, in a kind of standoff that can hold for seventy or eighty years without ever fully eliminating the virus from the tissue where it is hiding.

What Actually Triggers the Reactivation

Shingles happens when that standoff breaks down and the dormant virus starts replicating again, traveling back down the same nerve pathway it originally used to reach the skin. The single biggest driver is a weakening of cell-mediated immunity that comes with normal aging, which is why shingles risk climbs steadily after age fifty and continues rising into the eighties and nineties. The CDC notes that about one in three people in the United States will develop shingles at some point in their lifetime, with an estimated one million new cases occurring in the country every year. Reactivation can also be triggered by anything else that suppresses immune function on a shorter timeline, including chemotherapy, organ-transplant medications, HIV infection, and significant physical or emotional stress, though in many cases no single trigger is ever identified and the virus simply reactivates on its own schedule.

The Telltale Band of Blisters

What makes the shingles rash recognizable to clinicians on sight is its pattern rather than its appearance alone. Because the virus reactivates in one specific nerve root, the rash follows the exact strip of skin, called a dermatome, that the nerve supplies, producing a band of blisters on one side of the body that stops abruptly at the midline rather than crossing to the other side. The rash is frequently preceded by several days of burning, tingling, or stabbing pain in that same strip of skin before any blisters appear, which can make early shingles difficult to distinguish from other causes of localized pain until the characteristic rash shows up. The blisters themselves typically crust over within seven to ten days and clear within two to four weeks, though the nerve damage caused along the way can outlast the visible rash by a wide margin.

Postherpetic Neuralgia, the Complication That Outlasts the Rash

The most common and most feared complication of shingles is postherpetic neuralgia, a form of nerve pain that persists in the same area long after the rash itself has healed. The CDC’s clinical guidance describes postherpetic neuralgia as pain that can last for months or, in some cases, years after the rash resolves, and it becomes both more common and more severe with advancing age, making it a particular concern for patients in their seventies and beyond. Shingles that develops near the eye carries its own separate risk, since the virus can affect the cornea and threaten vision if it is not treated promptly with antiviral medication. Because nerve damage from shingles is largely irreversible once it sets in, the window for starting antiviral treatment, ideally within seventy-two hours of the rash appearing, matters more for preventing long-term pain than for shortening the rash itself.

The Vaccine Built to Head It Off

The main tool for preventing shingles in the first place is a recombinant vaccine rather than a live attenuated one, a distinction that matters for people with weakened immune systems who cannot safely receive live-virus vaccines. The CDC recommends two doses of this recombinant zoster vaccine for all adults fifty and older, along with adults nineteen and older who have weakened immune systems due to disease or treatment, spaced two to six months apart for full protection. The vaccine does not eliminate the dormant virus already sitting in nerve tissue, since there is currently no way to clear it from the body entirely, but it trains the immune system to suppress reactivation far more effectively than aging immunity does on its own, which is the same mechanism that let the virus reactivate in the first place.

This article was produced with the assistance of AI and reviewed by Morning Overview editors.

More from Morning Overview